Aplidine evaluated for activity in animal models of lymphoma, prostate and gastric cancer April 9, 1998 No Comments
PKCbeta inhibitor from Lilly may potentiate effects of radio- and chemotherapy April 9, 1998 No Comments
New cell therapy developed at Wistar Institute shows potential as chemotherapy adjuvant April 9, 1998 No Comments
Flk-1/KDR receptor tyrosine kinase inhibitor SU-5416 characterized at ACS meeting April 9, 1998 No Comments
EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing April 9, 1998 No Comments
RSS